Drug Testing Equipment Market Share

North American Market Forecast

The drug testing equipment market in North America is projected to be the largest with a share of about 40% by the end of 2036. The existence of giant players in the industry encouraging drug screening in the region with the increasing concern of augmenting drug abuse in countries such as the United States and the growing implementation of strict norms to vigorously tackle the drug problem. As per recent data from 2023, Americans constitute 12% of global drug users.

APAC Market Statistics

The Asia Pacific drug testing equipment market is estimated to register a growth rate of 21% through 2036. The growing use of substance abuse in the region and the rising prevalence of drug trafficking and the adoption of concealment methods and cross-border operations in South-East Asia specifically in Myanmar, Thailand, and Vietnam is leading to the stringent regulatory frameworks which is resulting in the expansion of drug testing equipment demand.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of drug testing equipment is estimated at USD 7.36 Billion.

The drug testing equipment market size was over USD 6.68 Billion in 2023 and is anticipated to cross USD 26.86 Billion by the end of 2036, witnessing more than 11.3% CAGR during the forecast period i.e., between 2024-2036. The rising use of intoxicants and controlled substances and the rising misuse of prescribed medicines are the major factors driving the market growth.

North America industry is poised to hold 40% of the revenue share by 2036, driven by existence of giant players in the industry encouraging drug screening in the region.

Sandoz International GmbH, Quest Diagnostics Incorporated, Butterfly Network, Inc., F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Cordant Health Solutions, Legacy Medical Services, LLC, Omega Laboratories, Inc., GE Healthcare

Drug Testing Equipment Market Share